Revealed: 2 Cheap Cannabis Stocks in September

Namaste Technologies Inc. (TSXV:N) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) both look like bargain picks ahead of edible legalization.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cannabis stocks have been in a rut in the summer of 2019. Even during its best stretches, this sector has been volatile. Investors who are on the hunt for growth should be looking for discounts in the cannabis space in early September. Today, I want to look at two cannabis stocks that still have explosive potential.

In early August, I’d discussed why Namaste Technologies (TSXV:N) looked like a bargain. The stock was trading close to 52-week lows, which coincided with a rout in the broader sector. The company had released a positive second-quarter report in July and made a promising purchase agreement with an Alberta-based chocolate maker. Cannabis edibles are set for legalization next month.

Namaste stock has climbed 35% over the past month. It has enjoyed a big jump in early September, as investors are again warming up to it after a corporate restructuring brought on a sharp correction. E-commerce has been a huge disruptor in the retail space. Namaste operates as many as 30 different websites across 20 countries. It possesses a user base of 1.5 million.

Canada has had an especially frustrating brick-and-mortar rollout, making the e-commerce side a much more attractive stream right now. Namaste aims to establish itself as the Amazon of cannabis. This is a lofty goal as the industry is still very young, but Namaste has carved out a global presence very early in the game.

Shares of Namaste are still trading at the low end of its 52-week range. The stock has shot up into technically overbought territory due to its September rebound, but this should not scare off investors looking long term.

Canopy Growth (TSX:WEED)(NYSE:CGC) stock has enjoyed a marginal rebound in September, but shares have still plunged 36% over the last three months. It has made its way out of technically oversold territory, but the stock is still trading at the low end of its 52-week range. This stock is a nice complement to the micro-cap Namaste in your portfolio.

The largest cannabis company on the TSX has a flurry of products that will be launching in December. This could be one of the first big boosts Canopy receives from its partnership with Constellation Brands. Edibles are set to be big business in the cannabis space right away, and Canopy is ready to unveil many offerings including chocolate, vape pens, and cannabis-infused beverages.

There are also positive signs of movement for recreational cannabis south of the border. President Trump was typically mealy-mouthed when confronted with the prospect of federal legalization, but there is growing pressure from key voices in the Republican party to take a firmer stance. Canopy has positioned itself to enter the market quickly after its contingent agreement with U.S.-based Acreage Holdings, which is backed by former Republican Speaker of the House John Boehner.

Investors can expect to see its second-quarter results in November. I like Canopy at its current price ahead of edibles legalization.

Should you invest $1,000 in Cineplex right now?

Before you buy stock in Cineplex, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Cineplex wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »